SOLACI CongressesSOLACI-CACI `14.

SOLACI-CACI `14.

solaci
solaci
17809
0

Day by day, the best presentations and images of SOLACI-CACI ’14 Congress. April 23 to 25, 2014

// Live Cases

 


26-11
26-10
26-9
26-8
26-7
26-6
26-5
26-4
26-3
26-2

[Mostrar presentación de diapositivas]
1 2

Previous article
Congresos SOLACI – Institucional
Next article
Casos en Vivo SOLACI 2014
solaci
solaci

More articles by this author

SOLACI-SBHCI 23

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci - 0
✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words - Dra. Emma Miranda (MEX)...

SOLACI-SOCIME 22

solaci - 0
Here you will find the most relevant articles about the SOLACI-SOCIME 2022 Congress. If you cannot view the articles, click here.

SOLACI-CACI 21

solaci - 0
Here you will find the most relevant articles about the SOLACI-CACI 2021 Congress. If you cannot view the articles, click here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Congresses

SOLACI-SBHCI 23

Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.
solaci -
SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Dr. Andrés Rodríguez - 0
Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Dr. Juan Manuel Pérez - 0
Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 0
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...